Promoting wellbeing, equality, and support in breast cancer survivorship

A feasibility study of delivering a culturally adapted group-based breast cancer self-management intervention in a community setting, designed to enhance confidence to self-manage following treatment for primary breast cancer and promote peer support, among women from different ethnic and socio-economic backgrounds

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN14016157

Enrollment

Registered

2014-04-28

Start date

2014-05-01

Completion date

Unknown

Last updated

2018-07-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast cancer survivorship Cancer

Interventions

Intervention arm: Participants in the intervention arm with be invited to attend the PROWESS intervention. This is a culturally appropriate group based self-management intervention in a community sett

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 1.Patients diagnosed with primary invasive breast cancer 2. Completed active hospital based treatment in the last twelve months (likely to have included surgery, chemotherapy, radiotherapy) 3. Either continuing treatment on hormone therapies and monoclonal antibodies or Herceptin 4. Able to provide informed consent 5. English speaking

Exclusion criteria

Exclusion criteria: Patients with primary invasive breast cancer but who: 1. have completed hospital treatment MORE than 12 months ago 2. are receiving chemotherapy or radiotherapy treatment 3. are non English speaking 4. are not able to give written informed consent 5. have previously attended a cancer self-management/ survivorship course including Breast Cancer Care's Moving Forward course

Design outcomes

Primary

Measure	Time frame
Feasibility and acceptability of the culturally adapted self-management intervention for primary breast cancer patients from diverse ethnic and social backgrounds, which will be assessed using both quantitative and qualitative measures.	—

Secondary

Measure	Time frame
1. Self efficacy will be measured using the Self-Efficacy for Managing Chronic Disease 6item Measure. In the feasibility study this will be used to inform sample size calculations for the randomised controlled trial and to assess the feasibility/acceptability of obtaining this measure. 2. The acceptability and feasibility of obtaining the following measures will also be assessed to determine their use as secondary outcome measures in the subsequent randomised controlled trial: 2.1. Exercise behaviour 2.2. Diet awareness and readiness to change (adopted from the California Department of Public Health Nutrition Risk Screening Questionnaire) 2.3. Breast cancer knowledge 2.4. The Brief Illness Perception Questionnaire (BIPQ) 2.5. Quality of life (FACTB) 2.6. Hospital Anxiety and Depressions Scale (HADS) 2.7. The Friendship Scale	—

Measure

Time frame

1. Self efficacy will be measured using the Self-Efficacy for Managing Chronic Disease 6item Measure. In the feasibility study this will be used to inform sample size calculations for the randomised controlled trial and to assess the feasibility/acceptability of obtaining this measure. 2. The acceptability and feasibility of obtaining the following measures will also be assessed to determine their use as secondary outcome measures in the subsequent randomised controlled trial: 2.1. Exercise behaviour 2.2. Diet awareness and readiness to change (adopted from the California Department of Public Health Nutrition Risk Screening Questionnaire) 2.3. Breast cancer knowledge 2.4. The Brief Illness Perception Questionnaire (BIPQ) 2.5. Quality of life (FACTB) 2.6. Hospital Anxiety and Depressions Scale (HADS) 2.7. The Friendship Scale

—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026